Author:
Wasserman E.,Myara A.,Lokiec F.,Goldwasser F.,Trivin F.,Mahjoubi M.,Misset J.L.,Cvitkovic E.
Reference14 articles.
1. The clinical status of irinotecan (CPT-11), a novel water soluble camptothecin analogue: 1996;O'Reilly;Crit Rev Oncol/Hematol,1996
2. Modulation of glucur-onidation of SN-38, the active metabolite of irinotecan, by valproic acid and phenobarbital;Gupta;Cancer Chemother Pharmacol,1997
3. Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea;Gupta;Cancer Res,1994
4. UGT isoform 1.1 (UGT*1.1) glucuronidates SN-38, the active metabolite of irinotecan;Iyer;Proc Am Soc Clin Oncol,1997
5. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome;Bosma;N Engl J Med,1995
Cited by
184 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献